Peptide als Agonisten und/oder Inhibitoren der Amyloidbildung und/oder Zytotoxizitaet sowie der Verwendung bei der Alzheimer'schen Krankheit, beim Typ II Diabetes mellitus und bei spongiformen Encephalopathien

Abstract

New agonist (competitive inhibitor) and/or inhibitor of amyloid formation peptide is 3-15 amino acids in length and contains at least the active sequence GA. USE - The new peptide is useful for inhibiting amyloid formation and associated cytotoxicity in the treatment of type II diabetes mellitus, Alzheimer's disease and spongiform encephalopathies (e.g. CJD, scrapie and BSE)